The Scientist : Hepatocyte growth factor controls bone marrow rejection [7/6/2001]

Hepatocyte growth factor controls bone marrow rejection

Email: Tudor Toma - ttoma@mail.dntis.ro
News from The Scientist 2001, 2(1):20010607-02

7 June 2001

Acute graft-versus-host disease (GVHD) is a major complication of bone marrow transplantation. In June 1 Journal of Clinical Investigation, Takanori Kuroiwa and colleagues from Hyogo College of Medicine, Nishinomiya, Japan show that hepatocyte growth factor (HGF) — a potent mitogen for hepatocytes — ameliorates acute graft-versus-host disease and promotes hematopoietic function.

Password

> Forgot Password?
> FAQ
> Subscribe

Subscribing to The Scientist is easy and inexpensive.

And you can choose from many options. Try us out with an online day pass starting at only $4.95. Or, get it all with unlimited online access to The Scientist Archive and door-to-door delivery of our monthly print magazine.


	The Scientist also offers site licenses to institutions and organizations. When your librarian adds The Scientist to the library's collection, you can get unlimited online access through your place of work or study. Recommend The Scientist today